We are live on ! Find out more
XTNT icon

Xtant Medical Holdings

18 hedge funds and large institutions have $1.24M invested in Xtant Medical Holdings in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

0.93% less ownership

Funds ownership: 1.85%0.92% (-0.93%)

17% less capital invested

Capital invested by funds: $1.49M → $1.24M (-$249K)

18% less funds holding

Funds holding: 2218 (-4)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
18
Holders Change
-4
Holders Change %
-18.18%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
3
Closed
5
Calls
Puts
Net Calls
Net Calls Change

XTNT Hedge Fund Activity: Q1 2017 in Review

18 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q1 2017, worth a combined $1.24M — down 17% from $1.49M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of XTNT and 2 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 5 added.

The largest buyer was Virtu KCG Holdings, adding an estimated $82.1K. The largest seller was Goldman Capital Management, cutting an estimated $236K.

  • 18 institutional investors held Xtant Medical Holdings (XTNT) as of Q1 2017, down from 22 in Q4 2016.
  • Funds reported $1.24M of Xtant Medical Holdings stock for Q1 2017, down 17% quarter-over-quarter.
  • 2 funds opened new Xtant Medical Holdings positions in Q1 2017 and 5 closed out, a net change of -3 holders.
  • The largest Xtant Medical Holdings buyer in Q1 2017 was Virtu KCG Holdings, an estimated $82.1K added.
  • The largest Xtant Medical Holdings seller in Q1 2017 was Goldman Capital Management, an estimated $236K sold.

Based on aggregated 13F filings for Q1 2017.